Helical stent having struts in a transition zone that progressively increase in length

Abstract
A stent includes a central portion of helically wound undulations formed of struts, cylindrical end portions, and transition zones between the helical portion and the cylindrical portions. According to a first aspect of the invention, the torsional flexibility of the stent is maximized by having bridges connecting adjacent winding be interrupted by the maximum possible number of undulations. In a preferred design, each winding includes nineteen undulations around the circumference, bridges are provided every five undulations. According to a second aspect of the invention, uniform opening of the transition zone is achieved by altering the width, and thereby the flexibility, of a series of struts in accordance with their lengths. Specifically, the long transition zone struts are made wider.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


This invention relates broadly to arterial prosthesis. More particularly, this invention relates to vascular stents, and even more particularly to helical stents.


2. State of the Art


Transluminal prostheses are widely used in the medical arts for implantation in blood vessels, biliary ducts, or other similar organs of the living body. These prostheses are commonly known as stents and are used to maintain, open, or dilate tubular structures.


Stents are either balloon expandable or self-expanding. Balloon expandable stents are typically made from a solid tube of stainless steel. Thereafter, a series of cuts are made in the wall of the stent. The stent has a first smaller diameter configuration which permits the stent to be delivered through the human vasculature by being crimped onto a balloon catheter. The stent also has a second, expanded diameter configuration, upon the application, by the balloon catheter, from the interior of the tubular shaped member of a radially, outwardly directed force.


Self-expanding stents act like springs and recover to their expanded or implanted configuration after being compressed. As such, the stent is inserted into a blood vessel in a compressed state and then released at a site to deploy into an expanded state. One type of self-expanding stent is composed of a plurality of individually resilient and elastic thread elements defining a radially self-expanding helix. This type of stent is known in the art as a “braided stent”. Placement of such stents in a body vessel can be achieved by a device which comprises stent”. Placement of such stents in a body vessel can be achieved by a device which comprises an outer catheter for holding the stent at its distal end, and an inner piston which pushes the stent forward once it is in position. However, braided stents have many disadvantages. They typically do not have the necessary radial strength to effectively hold open a diseased vessel. In addition, the plurality of wires or fibers used to make such stents could become dangerous if separated from the body of the stent, where it could pierce through the vessel.


Therefore, recently, self-expanding stents cut from a tube of superelastic metal alloy have been manufactured. These stents are crush recoverable and have relatively high radial strength. U.S. Pat. No. 5,913,897 to Corso, U.S. Pat. No. 6,042,597 to Kveen, and WPO Patent Application WO 01/89421-A2 (with inventors Cottone and Becker, and referred to herein as “Cottone”) each teach superelastic cut-tubular stents having a helically wound configuration of repeating undulations. Bridge structures connect adjacent circumferential windings by extending between loop portions of undulations on adjacent windings. However, the bridge structures and arrangements do not maximize the torsional flexibility of the stents. In particular, Cottone describes a stent having a helical pattern of bridges (connections) connecting windings of the helix which is reverse in handedness from the undulations of the windings which form the central portion of the stent. The design described provides the stent with asymmetric characteristics that cause the stent to resist torsional deformations differently in one direction versus the other. In addition, each “helix of connections” forms a string of connections in which the connections are interrupted by only one and one-half undulations. As such, that string is resistant to stretching and compression. Accordingly, when a stent so designed is twisted torsionally, that string of connections causes constriction of the stent when twisted in the “tightening” direction (i.e., in the direction of the windings) and expansion of the stent when twisted in the opposite “loosening” direction. This differential torsional reaction results in the undulations of the stent being forced out of the cylindrical plane of the surface of the stent, such that the stent appears to buckle when twisted in the “loosening” direction.


In fact, even if the stent were constructed opposite to Cottone's preferred embodiment (that is, with a helix of bridges having the same handedness as the helix of undulations), the same effect results. Stents built with constructions containing a string of bridges separated by only a small number of undulations behave poorly when twisted. That is, they react differently if the stent is twisted one way versus the other, and the surface of the stent tends to buckle when twisted only slightly in the “loosening” direction.


Moreover, due to the helical windings of the stents, the stents described by Corso and Kveen terminate unevenly at the end of the helical windings. As such, the terminus of the final winding fails to provide a uniform radial expansion force 360° therearound. Cottone addresses this problem by providing a stent constructed with a helically wound portion of undulations in the central portion of the stent, a cylindrical portion of undulations at each end of the stent, and a transition zone of undulations joining each cylindrical portion to the central helically wound portion. The undulations of the transition zone include struts which progressively change in length.


Because the transition zone must mate directly to the cylindrical portion on one side and to a helically wound portion on the other side, the transition zone must create a free end from which the helical portion extends, must contain a bifurcation, and must depart from a uniform strut length for the struts around the circumference of the transition zone so that the transition from the helically wound portion to the cylindrical portion can occur.


However, if there are longer struts in a portion of the transition zone, that portion tends to expand more than the portion with shorter struts because the bending moments created by longer struts are greater than those created by shorter struts. Also, for the same opening angle between two such struts when the stent is in an expanded state, the opening distance between such struts is greater if the struts are longer. These two factors combine their effects in the portion of the transition zone with longer struts so that the apparent opening distances are much larger than in the portion where the struts are shorter. As such, the simple transition zone described by Cottone is not amenable to uniform expansion and compression, which is a requirement of an efficient self-expanding stent.


Moreover, except in the case of the Cottone helical stent which is provided with a transition zone, and except where there are different strut lengths in the undulations at the ends of a stent, stents generally contain struts of one length throughout their design. Accordingly, in order to achieve uniform opening of the stent, all the struts have substantially the same width as well as length.


SUMMARY OF THE INVENTION

It is therefore an object of the invention to provide a cut-tube self-expanding helical stent which has substantially equal torsional flexibility and resistance to torsional buckling when twisted in both directions.


It is another object of the invention to provide a cut-tube self-expanding helical stent having a transition zone and a cylindrical segment at each end thereof, and to improve the expandability of the transition zone.


It is a further object of the invention to provide a cut-tube self-expanding helical stent having a transition zone in which openings created between the struts of an expanded stent can be made more uniform over the entire transition zone.


In accord with the invention, which will be described in detail below, a cut-tube self-expanding stent having a central helically wound portion comprising repeating undulations formed of struts is provided at each of its ends with a cylindrical portion, and a transition zone between the helical portion and each cylindrical portion.


According to a first aspect of the invention, several criteria are set forth which together provide for optimal torsional flexibility and expandability in a self-expanding helically wound stent. According to a first criterion, the torsional flexibility of the stent is maximized by having all the “strings” of bridges which connect adjacent helical winding be interrupted by the maximum possible number of undulations. This results in these bridge strings being as stretchy and compressible as possible. According to a second criterion, the undulations in the central portion are interdigitated. According to a third criterion, preferred numbers of undulations, bridges, and undulations between bridges are provided. According to a fourth criterion, the bridges preferably extend in a “short” direction, longitudinally crosswise across the helically space separating the helical windings of undulations. Most preferably, the bridges join loops of undulations which are out of phase by one and one-half undulations.


According to a second aspect of the invention, uniform opening of the transition zone is achieved by altering the flexibility of a series of struts in accordance with their lengths. Specifically, the long transition zone struts are made wider (in the cylindrical plane) to compensate for the greater bending moments imposed by the longer struts. This keeps the opening distance (the distance between the open ends of adjacent struts in an expanded stent) approximately constant throughout the transition zone. More particularly, in a typical transition zone, the shortest strut must be approximately half the length of the longest strut. In order to maintain similar opening distances, the long struts should be wider by approximately the cube root of 2 squared, i.e. approximately 1.59. The ratio may be adjusted to a value near this ratio in order to achieve a uniform opening, giving consideration to the fact that in a transition zone two adjacent struts of unequal length both contribute to the bending moment on the flexing connection that joins them. The ratio may also be adjusted to make the opening angle of the shortest strut pairs not exceed a certain value in order to limit the maximum strains experienced in that portion of the transition zone.


Additional objects and advantages of the invention will become apparent to those skilled in the art upon reference to the detailed description taken in conjunction with the provided figures.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a broken flattened view of a helical stent according to the invention in an unexpanded state, wherein the stent has been cut parallel to its longitudinal axis and laid flat;



FIG. 2 is an enlarged broken flattened view of a central portion of the helical stent of FIG. 1;



FIG. 3 is an enlarged broken flattened view of a transition zone portion of the helical stent of FIG. 1; and



FIG. 4 is a schematic view of a plurality of struts of the transition zone of FIG. 3 shown in an open configuration.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

Turning now to FIG. 1, a helical stent 10 according to the invention is shown. The stent has a collapsed configuration with a first smaller diameter for insertion into a body vessel, and self-expands to an expanded or deployed configuration with a second larger diameter for deployment within the vessel. The stent is preferably a laser-cut tubular construction of a superelastic metal alloy such as nickel-titanium.


The stent 10 includes a central portion 12, a cylindrical portion 14 at each end of the stent 10, and a transition zone 16 between the central portion 12 and each cylindrical end portion 14. The central portion 12 is comprised of a plurality of helical circumferential windings (single turns of a helix) 18 of substantially like undulations (in length and width) 20, with each undulation 20 being defined by two adjacent struts, e.g., struts 22, 24, and a loop 26 connecting the struts (FIG. 2). The cylindrical end portion 14 is comprised of preferably a single cylindrical winding 28 of like undulations 30, with each such undulation 30 being defined by two adjacent struts, e.g., struts 32, 34, and a loop 36 connecting the struts. Optionally, one or more structures 37 adapted to receive or otherwise be coupled to radiopaque markers (not shown) can be provided at the ends of one or more of the undulations 30. The transition zone 16 is comprised of preferably a single winding 38 of undulations 40 that preferably progressively increase in size, with each such undulation 40 being defined by two adjacent struts, e.g., struts 42, 44, and a loop 46 connecting the struts.


In each of sections 12, 14 and 16, the undulations 20, 30, 40 extend in a generally longitudinal direction. That is, when the stent is in a collapsed configuration, as shown in FIG. 1, struts of the helical portion (e.g., 22 and 24), cylindrical portion (e.g., 32 and 34) and transition zone (e.g., 42 and 44) all extend substantially parallel to the longitudinal axis AL of the stent. In the expanded configuration, adjacent struts are moved apart and angled relative to each other.


Referring to FIG. 2, particularly with respect to the central portion 12, as the windings 18a, 18b, 18c are longitudinally displaced along the length of the stent, bridges, e.g. 50, 52, 54 and 56, are provided to connect together the loops 26 of undulations 20 on adjacent windings, e.g. 18a and 18b, and 18b and 18c, to prevent stent unwinding. The bridges 50, 52, 54, 56 can be seen to be arranged in right-handed and left-handed helical “strings” (right-handed string 60 and left-handed string 62) which extend about the stent.


There are several preferred design considerations (criteria) which, according to the invention, are preferably used together to identify a desired number and placement of undulations in any winding and a number and placement of bridges 50, 52, 54, 56 which connect together loops 26 of undulations on adjacent windings (and thereby connect together the windings 18a, 18b, 18c). If the central portion 12 is designed in accord with the following criteria, the central portion 12 will have a desired torsional flexibility and expandability; i.e., be not too stiff, but also be sufficiently flexible so that the central portion 12 will not be subject to kinking.


In accord with a first criterion, the pattern of bridges is as symmetric as possible. That is, the right-handed and left-handed strings 60, 62 of bridges should be as similar as possible. Further, the torsional flexibility of the stent is maximized by having each string 60, 62 of bridges be interrupted by the maximum possible number of undulations 20. This results in the bridge strings being as stretchy and compressible as possible. In any given stent design, there is a certain number of undulations which form a complete circumferential winding (single turns of the helical portion). The number of undulations 20 which separate the bridges lying along any one string depends, therefore, on the number of bridges within a complete circumferential winding. For example, if there are eighteen undulations around a circumferential winding and three bridges, and if the bridges on adjacent windings are staggered, in accord with the invention there should be three undulations separating bridges along each helical strings of bridges.


In accord with a second criterion, it is preferred that the loops 26 of the undulations 20 of the central portion 12 be interdigitated between the loops of the undulations on an adjacent winding. For example, if there are eighteen undulations around the circumference, each undulation would be rotationally displaced from the undulations on the adjacent winding by one-half an undulation (i.e., one thirty-sixth of a circle or ten degrees), so that the “peak” of one loop is directed into the “valley” between two loops on an adjacent winding.


In accord with a third criterion, it is necessary to observe how the number (m) of undulations between bridges and the number (n or n+½) of undulations around the circumference interact to create helical strings of bridges. That is, with an increase in n for a stent of a given diameter, the stent is weakened and subject to kinking. This is because, for a stent of a given diameter, by providing more struts, narrower and weaker struts must be used. As n is decreased, the struts are increased in width and thus stiffness. However, while this may strengthen the stent, the stent is nevertheless limited in flexibility and may be undesirably stiff. In accord with the invention, for the optimum combination of strength and flexibility, it is preferred that n (i.e. the number of undulations) be sixteen to twenty, and more preferably eighteen to nineteen, where n may optionally be a non-integer. In addition, the number of bridges, m, for the preferred number of struts is most preferably three to five bridges per circumferential winding.


In accord with a fourth criterion, consideration must be made as to the locations between which the bridges connect and the direction in which the bridges extend. In accord with the preferred interdigitated criterion, the bridges cannot extend parallel to the longitudinal axis AL of the stent. Rather, they preferably extend across loops located one and one-half pitches away; i.e., each bridge connects over two struts relative to directly across from the strut from which the bridge extends. In addition, the bridges extend longitudinally crosswise across the helical space separating the adjacent loops (i.e. in a “short” direction), as opposed circumferentially along the helical space separating the adjacent loops (i.e., in a “long” direction).


In view of the above, a preferred exemplar central portion 12 of the stent 10 illustrating the application of the above criteria is now described. Referring to FIG. 2, the central portion 12 of the stent 10 includes repeating undulations 20 (each comprising two struts 22, 24 and a loop 26) that are helically wound in circumferential windings 18a, 18b, 18c, etc. There are preferably nineteen undulations 20 in each circumferential winding 18a, 18b, 18c and the undulations are interdigitated. With reference to windings 18b and 18c, a bridge 50, 52, 54 is located every five undulations therebetween, and each bridge joins loops of undulations on the adjacent windings 18a, 18b which are one and one-half pitches away (or two struts over from directly across) in the “short” direction. That is, all bridges in the central portion 12 of the stent preferably extend in the same direction, longitudinally crosswise across the helical space. This preferred exemplar embodiment provides a very symmetrical distribution of bridges. In particular, traveling from any one bridge, e.g. bridge 54, to the next bridge, e.g. bridge 56, along the right-hand string 60 of bridges, traverses exactly two and one half undulations (or five struts 70, 72, 74, 76 and 78). Moreover, traveling from any one bridge, e.g. bridge 52, to the next bridge, e.g. bridge 56, along the left-handed string 62 of bridges, also traverses exactly two and one half undulations (or five struts 80, 82, 84, 86 and 88). This design gives very even torsional flexibility and expandibility, and the stent may be twisted considerably in either direction without buckling.


Referring now to FIG. 3, the transition zone 16 of the stent 10 is shown. The transition zone, as stated above, includes struts that progressively increase in length. The long transition zone struts 90, 92 are relatively wider (in the cylindrical plane) than the shorter transition zone struts 94, 96 to compensate for the greater bending moments imposed by the longer struts. Moreover, even the shortest transition zone strut 98 is preferably longer and wider than the struts 22, 24 of the central portion 12.


More particularly, referring to FIGS. 3 and 4, for substantially uniform expansion of the stent, it is desirable for the opening distance D (i.e., the distance between the ends of two adjacent struts, e.g. struts 32 and 34, when the stent is in an open configuration) to be approximately even throughout the transition zone 16. Accordingly, the opening angle a between pairs of longer struts in the transition zone, e.g. struts 32 and 34, must be smaller than the opening angle a between shorter struts, e.g. struts 94 and 96. In addition, the bending stiffness of the longer struts must be even greater than in proportion to their increased bending moment. The bending stiffness S of a rectangular-section beam is in proportion to the third power of the width (in the bending direction) W. As such, by way of example, in order to double the bending stiffness of a strut, the width W of the strut must be increased by the cube root of two.


Referring now to FIG. 3, the transition zone 16 of the stent 10 is shown. The transition zone, as stated above, includes struts that progressively increase in length. The long transition zone struts 90, 92 are relatively wider (in the cylindrical plane) than the shorter transition zone struts 94, 96 to compensate for the greater bending moments imposed by the longer struts. Moreover, even the shortest transition zone strut 98 is preferably longer and wider than the struts 22, 24 of the central portion 12. In the embodiment shown in FIG. 3, a terminal end of a strut of the central portion 12 adjoins one longer strut between the opposing ends of the one longer strut. In this embodiment, the one longer strut is connected to the shortest transition zone strut 98.


In a preferred transition zone, the shortest strut 98 should be approximately half the length of the longest strut 42. Therefore, in order to maintain similar opening distances, the longer struts are most preferably wider by the cube root of 2 squared, or 1.59, relative to the shorter struts. The ratio may be adjusted to a value near this ratio (e.g., ±25%, or 1.19 to 1.99) in order to achieve a uniform opening, giving consideration to the fact that in a transition zone two adjacent struts of unequal length both contribute to the bending moment on the flexing connection that joins them. It may also be desirable to make the opening angle a between the shortest strut pairs not exceed a certain value in order to limit the maximum strains experienced in that portion of the transition zone.


As such, uniform opening is achieved in the transition zone by altering the flexibility of a series of struts in accordance with their lengths.


There have been described and illustrated two aspects of a preferred stent relating to the helical central portion and the transition zone. While particular embodiments of the invention have been described, it is not intended that the invention be limited thereto, as it is intended that the invention be as broad in scope as the art will allow and that the specification be read likewise. Thus, the two preferred aspects (relating to the central helical portion and the transition zone) can be used together or separately. Moreover, each of the design considerations relating to the helical central portion can be used alone or together with one or more of the other considerations. It will therefore be appreciated by those skilled in the art that yet other modifications could be made to the provided invention without deviating from its spirit and scope as claimed.

Claims
  • 1. A stent for insertion into a vessel of a patient, comprising: a central portion comprised of a plurality of helical circumferential windings, each of said windings including a plurality of undulations, with each said undulation being defined by two adjacent struts connected together, each of the two adjacent struts having a same strut length,wherein a same number of struts is traversed from any one bridge to a next bridge on each of said windings when traveling along the windings either from a first circumferential location to a second circumferential location spaced from the first circumferential location or from the second circumferential location to the first circumferential location, the same number of struts being determined by identifying the any one bridge disposed on one side of one of said windings and counting the number of struts traversed to reach the next bridge disposed on an opposite side of the one of said windings, at least one cylindrical end portion at an end of said central portion; anda transition zone disposed between said central portion and each of said cylindrical end portions, said transition zone including a plurality of transition undulations having struts that progressively increase in length and defining longer struts that are longer than a shortest strut of the transition zone, each of the longer struts having opposing ends connected to loops adjoining adjacent struts, a terminal end of a strut of the central portion adjoining one longer strut between the opposing ends of the one longer strut,wherein a relatively longer strut of said transition undulations has a relatively wider width than a relatively shorter strut of said transition undulations.
  • 2. The stent of claim 1, wherein: said longest strut of said transition undulations is 1.19 to 1.99 times wider than said shortest strut of said transition undulations.
  • 3. The stent of claim 1, wherein: said longest strut of said transition undulations is approximately 1.59 times wider than said shortest strut of said transition undulations.
  • 4. The stent according to claim 1, wherein: each strut of said central portion having a common strut length and a common strut width.
  • 5. The stent according to claim 1, wherein: said common strut length of each of said struts of said central portion is shorter than the shortest strut of said transition zone, andsaid common strut width of each of said struts of said central portion is narrower than a narrowest strut of said transition zone.
  • 6. The stent of claim 1, the one longer strut being a longest strut of the transition zone.
CROSS REFERENCE TO A RELATED PATENT APPLICATION

This application is a continuation of U.S. patent application Ser. No. 10/231,666, filed Aug. 30, 2002, now U.S. Pat. No. 6,878,162, titled “HELICAL STENT HAVING IMPROVED FLEXIBILITY AND EXPANDABILITY”, the disclosure of which is incorporated by reference herein in its entirety.

US Referenced Citations (159)
Number Name Date Kind
4886062 Wiktor Dec 1989 A
5091205 Fan Feb 1992 A
5292331 Boneau Mar 1994 A
5314472 Fontaine May 1994 A
5356423 Tihon et al. Oct 1994 A
5370683 Fontaine Dec 1994 A
5421955 Lau et al. Jun 1995 A
5514154 Lau et al. May 1996 A
5540712 Kleshinski et al. Jul 1996 A
5562697 Christiansen Oct 1996 A
5569295 Lam Oct 1996 A
5591197 Orth et al. Jan 1997 A
5630829 Lauterjung May 1997 A
5649952 Lam Jul 1997 A
5653727 Wiktor Aug 1997 A
5665115 Cragg Sep 1997 A
5716393 Lindenberg et al. Feb 1998 A
5716396 Williams, Jr. Feb 1998 A
5725572 Lam et al. Mar 1998 A
5741327 Frantzen Apr 1998 A
5776161 Globerman et al. Jul 1998 A
5780807 Saunders Jul 1998 A
5800456 Maeda et al. Sep 1998 A
5800520 Fogarty et al. Sep 1998 A
5810870 Myers et al. Sep 1998 A
5810872 Kanesaka et al. Sep 1998 A
5824043 Cottone Oct 1998 A
5824059 Wijay Oct 1998 A
5843175 Frantzen Dec 1998 A
5861027 Trapp Jan 1999 A
5868781 Killion Feb 1999 A
5879381 Moriuchi et al. Mar 1999 A
5891191 Stinson Apr 1999 A
5895406 Gray et al. Apr 1999 A
5902317 Kleshinski et al. May 1999 A
5906639 Rudnick et al. May 1999 A
5911754 Kanesaka et al. Jun 1999 A
5913897 Corso, Jr. et al. Jun 1999 A
5922021 Jang Jul 1999 A
5925061 Ogi et al. Jul 1999 A
5935162 Dang Aug 1999 A
5968088 Hansen et al. Oct 1999 A
5985061 Doi et al. Nov 1999 A
6013854 Moriuchi Jan 2000 A
6019789 Dinh et al. Feb 2000 A
6022374 Imran Feb 2000 A
6042597 Kveen et al. Mar 2000 A
6042605 Martin et al. Mar 2000 A
6053940 Wijay Apr 2000 A
6059808 Boussignac et al. May 2000 A
6059822 Kanesaka et al. May 2000 A
6063113 Karteladze et al. May 2000 A
6066167 Lau et al. May 2000 A
6117165 Becker Sep 2000 A
6129755 Mathis et al. Oct 2000 A
6190406 Duerig et al. Feb 2001 B1
6203568 Lombardi et al. Mar 2001 B1
6238409 Hojeibane May 2001 B1
6238430 Klumb et al. May 2001 B1
6245100 Davila et al. Jun 2001 B1
6248122 Klumb et al. Jun 2001 B1
6251135 Stinson et al. Jun 2001 B1
6273911 Cox et al. Aug 2001 B1
6293966 Frantzen Sep 2001 B1
6315794 Richter Nov 2001 B1
6325820 Khosravi et al. Dec 2001 B1
6342067 Mathis et al. Jan 2002 B1
6348065 Brown et al. Feb 2002 B1
6352552 Levinson et al. Mar 2002 B1
6361557 Gittings et al. Mar 2002 B1
6423091 Hojeibane Jul 2002 B1
6475236 Roubin et al. Nov 2002 B1
6485509 Killion et al. Nov 2002 B2
6485511 Lau et al. Nov 2002 B2
6488700 Klumb et al. Dec 2002 B2
6488701 Nolting et al. Dec 2002 B1
6488703 Kveen et al. Dec 2002 B1
6503271 Duerig et al. Jan 2003 B2
6517570 Lau et al. Feb 2003 B1
6520987 Plante Feb 2003 B1
6527938 Bales et al. Mar 2003 B2
6533807 Wolinsky et al. Mar 2003 B2
6537310 Palmaz et al. Mar 2003 B1
6551351 Smith et al. Apr 2003 B2
6572647 Supper et al. Jun 2003 B1
6585755 Jackson et al. Jul 2003 B2
6613081 Kim et al. Sep 2003 B2
6645237 Klumb et al. Nov 2003 B2
6656219 Wiktor Dec 2003 B1
6660019 Richter et al. Dec 2003 B1
6660032 Klumb et al. Dec 2003 B2
6719782 Chuter Apr 2004 B1
6730116 Wolinsky et al. May 2004 B1
6733524 Tseng et al. May 2004 B2
6740114 Burgermeister May 2004 B2
6755856 Fierens et al. Jun 2004 B2
6776794 Hong et al. Aug 2004 B1
6814746 Thompson et al. Nov 2004 B2
6852124 Cox et al. Feb 2005 B2
6862794 Hopkins Mar 2005 B2
6863685 Davila et al. Mar 2005 B2
6866669 Buzzard et al. Mar 2005 B2
6878162 Bales et al. Apr 2005 B2
6918928 Wolinsky et al. Jul 2005 B2
6923828 Wiktor Aug 2005 B1
6939352 Buzzard et al. Sep 2005 B2
6969402 Bales et al. Nov 2005 B2
6976994 Ballou et al. Dec 2005 B2
7004968 Lootz et al. Feb 2006 B2
7025777 Moore Apr 2006 B2
7033385 Eder et al. Apr 2006 B2
7037330 Rivelli, Jr. et al. May 2006 B1
7037331 Mitelberg et al. May 2006 B2
7128752 Bales Oct 2006 B2
7169175 Cottone, Jr. et al. Jan 2007 B2
7172623 Hansen et al. Feb 2007 B2
7243408 Vietmeier Jul 2007 B2
7326245 Rosenthal et al. Feb 2008 B2
7763067 Bales et al. Jul 2010 B2
7780721 Bales et al. Aug 2010 B2
8038707 Bales et al. Oct 2011 B2
8328865 Bales, Jr. et al. Dec 2012 B2
8333799 Bales, Jr. et al. Dec 2012 B2
20020035394 Fierens et al. Mar 2002 A1
20020143386 Davila et al. Oct 2002 A1
20020183826 Dorn et al. Dec 2002 A1
20020183831 Rolando et al. Dec 2002 A1
20020198601 Bales et al. Dec 2002 A1
20030040754 Mitchell et al. Feb 2003 A1
20030055485 Lee et al. Mar 2003 A1
20030074054 Duerig et al. Apr 2003 A1
20030093066 Peyman May 2003 A1
20030108659 Bales et al. Jun 2003 A1
20030216807 Jones et al. Nov 2003 A1
20040015229 Fulkerson et al. Jan 2004 A1
20040034402 Bales et al. Feb 2004 A1
20040044401 Bales et al. Mar 2004 A1
20040054398 Cully et al. Mar 2004 A1
20040122466 Bales Jun 2004 A1
20040153142 Klumb et al. Aug 2004 A1
20040267353 Gregorich Dec 2004 A1
20050060025 Mackiewicz et al. Mar 2005 A1
20050090890 Wu et al. Apr 2005 A1
20050107738 Slater et al. May 2005 A1
20050113798 Slater et al. May 2005 A1
20060004437 Jayaraman Jan 2006 A1
20060060266 Bales et al. Mar 2006 A1
20060064154 Bales et al. Mar 2006 A1
20060064155 Bales et al. Mar 2006 A1
20060064158 Bales et al. Mar 2006 A1
20060074480 Bales et al. Apr 2006 A1
20060195175 Bregulla Aug 2006 A1
20060211979 Smith et al. Sep 2006 A1
20070049965 Bales Mar 2007 A1
20080039919 Kaplan et al. Feb 2008 A1
20090204200 Bales, Jr. et al. Aug 2009 A1
20090264986 Bales et al. Oct 2009 A1
20130090719 Bales, Jr. et al. Apr 2013 A1
20130090721 Bales, Jr. et al. Apr 2013 A1
Foreign Referenced Citations (34)
Number Date Country
2155527 Aug 1994 CA
02544371 Apr 1976 DE
19539449 Apr 1997 DE
29522101 Dec 1999 DE
19901530 Jul 2000 DE
20019429 Mar 2002 DE
69521346 Apr 2002 DE
0688545 Dec 1995 EP
0712614 May 1996 EP
0732088 Sep 1996 EP
0790041 Aug 1997 EP
0792627 Sep 1997 EP
0945107 Sep 1999 EP
1132058 Sep 2001 EP
1155664 Nov 2001 EP
9618359 Jun 1996 WO
9628116 Sep 1996 WO
WO 9838945 Sep 1998 WO
WO 200016718 Mar 2000 WO
0024340 May 2000 WO
0049973 Aug 2000 WO
0050116 Aug 2000 WO
0132102 May 2001 WO
PCTUS0116431 May 2001 WO
0189421 Nov 2001 WO
2004109818 Dec 2004 WO
2006026777 Mar 2006 WO
2006026778 Mar 2006 WO
2006026779 Mar 2006 WO
2006026781 Mar 2006 WO
2006026782 Mar 2006 WO
2007003591 Jan 2007 WO
2008100780 Aug 2008 WO
2008100783 Aug 2008 WO
Non-Patent Literature Citations (66)
Entry
EP Application No. 05810201 filed Jan. 19, 2005 EP Search Report dated Aug. 7, 2008.
Haas, Schuessler, Welding and Joining of TiNi Shape Memory Alloys: Engineering Aspects and Medical Applications. Proceedings First European Conference on Shape Memory and Superelastic Technolgoies SMST-99, Belguim (1999).
Kastrati, A. Clinical Impact of Stent Design 2: Results From Randomized Trials TCT2003.
PCT/DE1999/002980 filed Sep. 20, 1999 Search Report dated Feb. 3, 2000.
PCT/EP2003/009570 filed Aug. 26, 2003 Search Report dated Mar. 11, 2004.
PCT/US2005/031556 filed Sep. 1, 2005 International Preliminary Report on Patentability dated Feb. 24, 2009.
PCT/US2005/031556 filed Sep. 1, 2005 Search Report on Patentability dated Jan. 17, 2008.
PCT/US2005/031556 filed Sep. 1, 2005 Written Opinion dated Jan. 6, 2008.
PCT/US2005/031557 filed Sep. 1, 2005 International Preliminary Report on Patentability dated Oct. 16, 2007.
PCT/US2005/031557 filed Sep. 1, 2005 Search Report dated Sep. 25, 2007.
PCT/US2005/031557 filed Sep. 1, 2005 Written Opinion dated Sep. 13, 2997.
PCT/US2005/031571 filed Sep. 1, 2005 International Preliminary Report on Patentability dated Mar. 6, 2007.
PCT/US2005/031571 filed Sep. 1, 2005 Search Report dated Aug. 30, 2006.
PCT/US2005/031571 filed Sep. 1, 2005 Written Opinion dated Jul. 14, 2006.
PCT/US2005/031618 filed Sep. 1, 2005 International Preliminary Report on Patentability dated Nov. 6, 2007.
PCT/US2005/031618 filed Sep. 1, 2005 Search Report dated Sep. 20, 2007.
PCT/US2005/031618 filed Sep. 1, 2005 Written Opinion dated Jul. 9, 2007.
PCT/US2005/031619 filed Sep. 1, 2005 International Preliminary Report on Patentability dated Sep. 11, 2007.
PCT/US2005/031619 filed Sep. 1, 2005 Search Report dated Jul. 27, 2007.
PCT/US2005/031619 filed Sep. 1, 2005 Written Opinion dated Jul. 13, 2007.
PCT/US2008/053319 filed Feb. 7, 2008 International Preliminary Report on Patentability dated Aug. 19, 2009.
PCT/US2008/053319 filed Feb. 7, 2008 Search Report dated Aug. 1, 2008.
PCT/US2008/053319 filed Feb. 7, 2008 Written Opinion dated Aug. 1, 2008.
PCT/US2008/053326 filed Feb. 7, 2008 Search Report dated Jul. 31, 2008.
PCT/US2008/053326 filed on Feb. 12, 2007 International Preliminary Report on Patentability dated Aug. 19, 2009.
PCT/US2008/053326 filed on Feb. 12, 2007 Written Opinion dated Jul. 31, 2008.
Siekmeyer, Steegmuller, Schrader, Hegel, Strobel, Schuessler, Novel Micro-Joining Techniques to Improve Stent Radiopacity, a Comparison of Welding and Riveting Processes, Proceedings of the MAterials & Processes for Medical Devices Conference, Boston (2005).
Standard Specification for Titanium and Titanium Alloy Bars and Billets.
Standard Specification for Unalloyed Titanium for Surgical Implant Applications UNS R50250, UNS R5044, UNS R50550, UNS R50700.
Stoeckel, Pelton, Duerig, Self-Expanding Nitinol Stents—Material and Design Considerations (ndc 2003).
U.S. Appl. No. 11/216,222, filed Aug. 31, 2005 Final Office Action dated Mar. 29, 2010.
U.S. Appl. No. 11/216,222, filed Aug. 31, 2005 Non-Final Office Action dated Aug. 18, 2009.
U.S. Appl. No. 11/216,228, filed Aug. 31, 2005 Final Office Action dated Aug. 12, 2009.
U.S. Appl. No. 11/216,228, filed Aug. 31, 2005 Final Office Action dated Jul. 26, 2007.
U.S. Appl. No. 11/216,228, filed Aug. 31, 2005 Non-Final Office Action dated Apr. 21, 2008.
U.S. Appl. No. 11/216,228, filed Aug. 31, 2005 Non-Final Office Action dated Mar. 6, 2007.
U.S. Appl. No. 11/216,228, filed Aug. 31, 2005 Non-Final Office Action dated Nov. 26, 2008.
U.S. Appl. No. 11/216,228, filed Aug. 31, 2005 Notice of Allowance dated Mar. 16, 2010.
U.S. Appl. No. 11/216,293, filed Aug. 31, 2005 Final Office Action dated Dec. 4, 2009.
U.S. Appl. No. 11/216,293, filed Aug. 31, 2005, Declaration of Achim Zipse Under 37 C.F.R. 1.132, Germany, Aug. 3, 2010.
U.S. Appl. No. 11/216,293, filed Aug. 31, 2005, Declaration of Thomas Haas Under 37 C.F.R. 1.132, Germany, Aug. 3, 2010.
U.S. Appl. No. 11/216,293, filed Aug. 31, 2009 Non-Final Office Action Feb. 19, 2009.
U.S. Appl. No. 11/216,362, filed Aug. 31, 2005 Final Office Action dated Aug. 15, 2007.
U.S. Appl. No. 11/216,362, filed Aug. 31, 2005 Final Office Action dated Feb. 19, 2009.
U.S. Appl. No. 11/216,362, filed Aug. 31, 2005 Non-Final Office Action dated Dec. 13, 2007.
U.S. Appl. No. 11/216,362, filed Aug. 31, 2005 Non-Final Office Action dated Mar. 6, 2007.
U.S. Appl. No. 11/216,362, filed Aug. 31, 2005 Non-Final Office Action dated Sep. 30, 2009.
U.S. Appl. No. 11/216,362, filed Aug. 31, 2005 Non-Final Office Action dated Sep. 4, 2008.
U.S. Appl. No. 11/216,362, filed Aug. 31, 2005 Notice of Allowance dated Apr. 22, 2010.
U.S. Appl. No. 12/465,354, filed May 13, 2009 Non-Final Office Action dated Oct. 18, 2010.
Designation: ASTM F67—06 Standard Specification for Unalloyed Titanium, for Surgical Implant Applications (UNS R50250, UNS R50400, UNS R50550, UNS R50700) Active Standard ASTM F67 Developed by Subcommittee: F04.12, Book of Standards vol. 13.01.
Designation: ASTM B348—05 Standard Specification for Titanium and Titanium Alloy Bars and Billets Active Standard ASTM B348 Developed by Subcommittee: B10.01, Book of Standards vol. 02.04.
PCT/US2007/061917 filed Dec. 9, 2007 International Preliminary Report on Patentability dated Aug. 19, 2008.
PCT/US2007/061917 filed Dec. 9, 2007 Search Report dated Mar. 17, 2008.
PCT/US2007/061917 filed Dec. 9, 2007 Written Opinion dated Mar. 17, 2008.
U.S. Appl. No. 11/216,293, filed Aug. 31, 2009 Decision on Appeal dated Jul. 24, 2012.
U.S. Appl. No. 12/226,030, filed Mar. 31, 2009 Advisory Action dated Jan. 3, 2011.
U.S. Appl. No. 12/226,030, filed Mar. 31, 2009 Final Office Action dated Oct. 27, 2010.
U.S. Appl. No. 12/226,030, filed Mar. 31, 2009 Non-Final Office Action dated Apr. 12, 2010.
EP Application No. 10177855.3 filed Aug. 26, 2003 Examination Report dated Apr. 12, 2012.
U.S. Appl. No. 12/465,354, filed May 13, 2009 Notice of Allowance dated Jun. 17, 2011.
U.S. Appl. No. 12/526,711, filed Jun. 11, 2010 Final Office Action dated May 14, 2012.
U.S. Appl. No. 12/526,711, filed Jun. 11, 2010 Non-Final Office Action dated Dec. 7, 2011.
EP 05796577.4 European Seach Report dated Feb. 12, 2013.
EP 05796752.3 European Search Report dated Mar. 26, 2013.
U.S. Appl. No. 11/216,293, filed Aug. 31, 2009 Non-Final Office Action dated Feb. 1, 2013.
Related Publications (1)
Number Date Country
20050159807 A1 Jul 2005 US
Continuations (1)
Number Date Country
Parent 10231666 Aug 2002 US
Child 11074806 US